Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05212506
What this trial is testing

Correlation Analysis of Covid-19 IgG Antibody Level in Seminal Plasma and Semen Index

Who this might be right for
Covid-19IgG AntibodySemen Index
Shanghai First Maternity and Infant Hospital 100
Not applicableStudy completedNCT01583972
What this trial is testing

Efficacy of Newborn Vitamin A Supplementation in Improving Immune Function

Who this might be right for
Vitamin A Deficiency
USDA, Western Human Nutrition Research Center 300
Post-approval studies (Phase 4)Study completedNCT05502081
What this trial is testing

Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Mansoura University Hospital 265
Not applicableUnknownNCT06435403
What this trial is testing

SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia

Who this might be right for
SARS CoV 2 InfectionCOVID-19 BreakthroughCOVID-19 Recurrent
Michael Hoelscher 1,000
Not applicableStudy completedNCT04638335
What this trial is testing

What is the Anti-HAV Seroprevalence of Travelers >60 Years or Having Lived in a Tropical Country for >5 Years

Who this might be right for
Hepatitis A
University of Lausanne Hospitals 50
Not applicableLooking for participantsNCT05973084
What this trial is testing

COVID-19 Transmission and Morbidity in Malawi

Who this might be right for
SARS CoV 2 InfectionSARS CoV 2 Vaccination
Boston University 1,500
Large-scale testing (Phase 3)Study completedNCT06039449
What this trial is testing

Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

Who this might be right for
COVID-19SARS-CoV-2
Invivyd, Inc. 790
Testing effectiveness (Phase 2)Study completedNCT02850016
What this trial is testing

Romidepsin Plus 3BNC117 Phase 2a Study

Who this might be right for
Human Immunodeficiency Virus (HIV)
Rockefeller University 48
Not applicableUnknownNCT04910971
What this trial is testing

Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year

Who this might be right for
COVID-19 VaccineCorona Virus InfectionVaccine Adverse Reaction+3 more
LifeBridge Health 60
Testing effectiveness (Phase 2)WithdrawnNCT01272258
What this trial is testing

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

Who this might be right for
HIV
CytoDyn, Inc.
Not applicableStudy completedNCT03542227
What this trial is testing

Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine

Who this might be right for
Human Papilloma Virus Infection
Universiteit Antwerpen 63
Large-scale testing (Phase 3)Study completedNCT00514605
What this trial is testing

Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection

Who this might be right for
HIV Infections
bioLytical Laboratories 2,500
Not applicableUnknownNCT05274373
What this trial is testing

Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization

Who this might be right for
COVID-19 PneumoniaCOVID-19
Nordsjaellands Hospital 47
Testing effectiveness (Phase 2)Looking for participantsNCT05769816
What this trial is testing

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)

Who this might be right for
Chronic Hepatitis bAnti-PD-1 Antibody
The Second Affiliated Hospital of Chongqing Medical University 120
Testing effectiveness (Phase 2)Study completedNCT04453384
What this trial is testing

Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

Who this might be right for
SARS Virus
Nantes University Hospital 416
Not applicableUnknownNCT05128760
What this trial is testing

Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)

Who this might be right for
Antiphospholipid SyndromeCOVID-19
Central Hospital, Nancy, France 161
Post-approval studies (Phase 4)WithdrawnNCT02124785
What this trial is testing

Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®

Who this might be right for
Hepatitis A
GlaxoSmithKline
Not applicableStudy completedNCT05745948
What this trial is testing

COVID-19 ANtibody Responses in Cystic Fibrosis: CAR-CF

Who this might be right for
COVID-19Cystic Fibrosis
Hospital Universitari Vall d'Hebron Research Institute 75
Early research (Phase 1)Active Not RecruitingNCT04340596
What this trial is testing

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 118
Large-scale testing (Phase 3)Looking for participantsNCT07655180
What this trial is testing

Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

Who this might be right for
COVID-19
Invivyd, Inc. 210
Next Page